Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus ketorolac for post-lobectomy pain control
IRCT20180521039753N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in postoperative pain comparing Ketorolac with Dexmedetomidine (2 arms). Primary endpoint: Pain intensity. Started May 2018; status: completed.
02
Drugs
dexmedetomidineketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20180521039753N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180521039753N1.